Recent studies have illuminated the intricate mechanisms of inflammation in the context of mild traumatic...
Inflammation
Evommune is heading to the New York Stock Exchange this morning via a $150 million...
Inflammation biotech Evommune plans to take the leap into public waters with an expected initial...
Will the return of biotech IPOs become the hottest fashion trend this fall? It’s still...



